Sign in
Taking people in United StatesEarly phase 1

Cocaine and Pentoxifylline (BED IN 47)

Key facts

Who runs it
William Stoops
Where
Lexington, United StatesSee the site
Trial code
Status
Recruiting
Phase
Early phase 1
People taking part
30 people, planned
Started
10 Nov 2025
Expected to end
28 Feb 2028
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Placebo
  • Cocaine (IV)
  • Pentoxifylline
Record updated
8 June 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • able to speak/read English,
  • not seeking treatment for drug use at the time of the study,
  • female or male between the ages of 18 and 55 years,
  • recent smoked or intravenous cocaine use verified by benzoylecgonine positive urine, as well as fulfillment of DSM-5 diagnostic criteria for CUD,
  • judged to be medically and psychiatrically healthy by study physicians other than the diagnosis for CUD at the time of screening,
  • ECG, read by a cardiologist, within normal limits,
  • females using an effective form of birth control and not pregnant or breastfeeding and 8) no known contraindications or allergies to pentoxifylline

Who cannot take part

  • seeking treatment for drug use,
  • Self-reported history of head trauma, seizure, CNS tumors, or use of concomitant medications that lower seizure threshold, or first-degree family history of seizures
  • contraindications or allergies to pentoxifylline, and
  • unable to speak/read English,
  • under 18 years or over 55 years,
  • no recent smoked or intravenous cocaine use as indicated by benzoylecgonine negative urine and no DSM-5 diagnosis of CUD,
  • judged to be medically or psychiatrically unhealthy by study physicians at the time of screening,
  • ECG, read by a cardiologist, outside normal limits,
  • females not using an effective form of birth control or pregnant or breastfeeding,

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 55 years old?

Where in United States

  • Psychopharmacology of Addiction LaboratoryLexington, United StatesContact: William W Stoops, PhDTaking people

About the trial

What the trial wants to find out

This will be a human laboratory study evaluating the influence of pentoxifylline treatment on the effects of cocaine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.

The 3 groups in the trial

  • PlaceboPlacebo, for comparison

    Subjects will be treated daily with an oral placebo.

  • Pentoxifylline Dose 1Treatment being tested

    Subjects will be treated daily with oral pentoxifylline (1200 mg).

    Treatment: Placebo, Cocaine (IV), and Pentoxifylline

  • Pentoxifylline Dose 2Treatment being tested

    Subjects will be treated daily with oral pentoxifylline (1600 mg).

    Treatment: Placebo, Cocaine (IV), and Pentoxifylline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study With Pentoxifylline
Fit questions
Built from NCT07086794, who can take part
Record updated
8 June 2026